Tissue-Specific Extraction and Structural Elucidation of Actin-Tropomyosin-Myosin Complexes from Human and Rodent

Abstract

Muscle contraction and cellular motility depend on the complex interplay between myosin, actin, and associated proteins. Disruptions in these interactions are linked to various human diseases, including muscular dystrophies and cardiac conditions. In this study, we developed a tissue-extraction protocol to purify the actin–tropomyosin–myosin (ATM) complex and filamentous actin (F-actin) directly from human and mouse left ventricles, as well as from rat skeletal muscles. Utilizing cryo-electron microscopy (cryo-EM), we resolved the structures of the ATM complexes and F-actin derived from these tissues. Additionally, we extracted ATM complexes from mice carrying the hypertrophic cardiomyopathy (HCM) mutation R404Q and demonstrated how this mutation alters the formation of ATM complexes and the structural configuration in myosin. Our approach offers a general method for isolating intact ATM complexes directly from various mammalian tissues, providing insights into the structural basis of ATM complex formation and regulation in muscle function and disease.

Keywords

actin–tropomyosin–myosin complex / cryo-electron microscopy / muscle contraction

References

[1] J. S. Berg, B. C. Powell, and R. E. Cheney, “A Millennial Myosin Census,” Molecular Biology of the Cell 12 (2001): 780–794, https://doi.org/10.1091/mbc.12.4.780.

[2] L. M. Coluccio, “Myosins and Disease,” Advances in Experimental Medicine and Biology 1239 (2020): 245–316, https://doi.org/10.1007/978-3-030-38062-5_12.

[3] M. H. Doran and W. Lehman, “The Central Role of the F-Actin Surface in Myosin Force Generation,” Biology 10 (2021): 1221, https://doi.org/10.3390/biology10121221.

[4] J. Robert-Paganin, O. Pylypenko, C. Kikuti, H. L. Sweeney, and A. Houdusse, “Force Generation by Myosin Motors: A Structural Perspective,” Chemical Reviews 120 (2020): 5–35, https://doi.org/10.1021/acs.chemrev.9b00264.

[5] H. L. Sweeney and A. Houdusse, “Structural and Functional Insights Into the Myosin Motor Mechanism,” Annual Review of Biophysics 39 (2010): 539–557, https://doi.org/10.1146/annurev.biophys.050708.133751.

[6] K. C. Holmes, I. Angert, F. Jon Kull, W. Jahn, and R. R. Schröder, “Electron Cryo-Microscopy Shows How Strong Binding of Myosin to Actin Releases Nucleotide,” Nature 425 (2003): 423–427, https://doi.org/10.1038/nature02005.

[7] E. Behrmann, M. Müller, P. A. Penczek, H. G. Mannherz, D. J. Manstein, and S. Raunser, “Structure of the Rigor Actin-Tropomyosin-Myosin Complex,” Cell 150 (2012): 327–338, https://doi.org/10.1016/j.cell.2012.05.037.

[8] E. Brunello and L. Fusi, “Regulating Striated Muscle Contraction: Through Thick and Thin,” Annual Review of Physiology 86 (2024): 255–275, https://doi.org/10.1146/annurev-physiol-042222-022728.

[9] A. Grinzato, D. Auguin, C. Kikuti, et al., “Cryo-EM Structure of the Folded-Back State of Human β-Cardiac Myosin,” Nature Communications 14 (2023): 3166, https://doi.org/10.1038/s41467-023-38698-w.

[10] M. H. Doran, M. J. Rynkiewicz, D. Rasicci, et al., “Conformational Changes Linked to ADP Release From human Cardiac Myosin Bound to Actin-Tropomyosin,” Journal of General Physiology 155 (2023): e202213267, https://doi.org/10.1085/jgp.202213267.

[11] R. Gong, F. Jiang, Z. G. Moreland, et al., “Structural Basis for Tunable Control of Actin Dynamics by Myosin-15 in Mechanosensory Stereocilia,” Science Advances 8 (2022): eabl4733, https://doi.org/10.1126/sciadv.abl4733.

[12] M. J. Greenberg, T. Lin, H. Shuman, and E. M. Ostap, “Mechanochemical Tuning of Myosin-I by the N-Terminal Region,” Proceedings of the National Academy of Sciences of the United States of America 112 (2015): E3337–E3344, https://doi.org/10.1073/pnas.1506633112.

[13] F. Blanc, T. Isabet, H. Benisty, H. L. Sweeney, M. Cecchini, and A. Houdusse, “An Intermediate Along the Recovery Stroke of Myosin VI Revealed by X-Ray Crystallography and Molecular Dynamics,” Proceedings of the National Academy of Sciences of the United States of America 115 (2018): 6213–6218, https://doi.org/10.1073/pnas.1711512115.

[14] C. Risi, J. Eisner, B. Belknap, et al., “Ca²⁺-Induced Movement of Tropomyosin on Native Cardiac Thin Filaments Revealed by Cryoelectron Microscopy,” Proceedings of the National Academy of Sciences of the United states of America 114 (2017): 6782–6787, https://doi.org/10.1073/pnas.1700868114.

[15] S. Y. Khaitlina, “Tropomyosin as a Regulator of Actin Dynamics,” International Review of Cell and Molecular Biology 318 (2015): 255–291, https://doi.org/10.1016/bs.ircmb.2015.06.002.

[16] M. Bradshaw, J. M. Squire, E. Morris, et al., “Zebrafish as a Model for Cardiac Disease; Cryo-EM Structure of Native Cardiac Thin Filaments From Danio Rerio,” Journal of Muscle Research and Cell Motility 44 (2023): 179–192, https://doi.org/10.1007/s10974-023-09653-5.

[17] L. K. Gunther, J. A. Rohde, W. Tang, et al., “Converter Domain Mutations in Myosin Alter Structural Kinetics and Motor Function,” Journal of Biological Chemistry 294 (2019): 1554–1567, https://doi.org/10.1074/jbc.RA118.006128.

[18] K. H. Lee, G. Sulbarán, S. Yang, and R. Craig, “Interacting-Heads Motif Has Been Conserved as a Mechanism of Myosin II Inhibition Since Before the Origin of Animals,” Proceedings of the National Academy of Sciences of the United States of America 115 (2018): E1991–E2000, https://doi.org/10.1073/pnas.1715247115.

[19] M. Kaya, Y. Tani, T. Washio, T. Hisada, and H. Higuchi, “Coordinated Force Generation of Skeletal Myosins in Myofilaments Through Motor Coupling,” Nature Communications 8 (2017): 16036, https://doi.org/10.1038/ncomms16036.

[20] N. G. Laing, B. A. Laing, C. Meredith, et al., “Autosomal Dominant Distal Myopathy: Linkage to Chromosome 14,” American Journal of Human Genetics 56 (1995): 422–427.

[21] P. J. Lamont, B. Udd, F. L. Mastaglia, et al., “Laing Early Onset Distal Myopathy: Slow Myosin Defect With Variable Abnormalities on Muscle Biopsy,” Journal of Neurology, Neurosurgery & Psychiatry 77 (2006): 208–215, https://doi.org/10.1136/jnnp.2005.073825.

[22] D. V. Trivedi, A. S. Adhikari, S. S. Sarkar, K. M. Ruppel, and J. A. Spudich, “Hypertrophic Cardiomyopathy and the Myosin Mesa: Viewing an Old Disease in a New Light,” Biophysical Reviews 10 (2018): 27–48, https://doi.org/10.1007/s12551-017-0274-6.

[23] M. Kawana, J. A. Spudich, and K. M. Ruppel, “Hypertrophic Cardiomyopathy: Mutations to Mechanisms to Therapies,” Frontiers in Physiology 13 (2022): 975076, https://doi.org/10.3389/fphys.2022.975076.

[24] J. A. Spudich, “Three Perspectives on the Molecular Basis of Hypercontractility Caused by Hypertrophic Cardiomyopathy Mutations,” Pflügers Archiv—European Journal of Physiology 471 (2019): 701–717, https://doi.org/10.1007/s00424-019-02259-2.

[25] J. Robert-Paganin, D. Auguin, and A. Houdusse, “Hypertrophic Cardiomyopathy Disease Results From Disparate Impairments of Cardiac Myosin Function and Auto-Inhibition,” Nature Communications 9 (2018): 4019, https://doi.org/10.1038/s41467-018-06191-4.

[26] M. Ussowicz, A. Jaśkowiec, C. Meyer, et al., “A Three-Way Translocation of MLL, MLLT11, and the Novel Reciprocal Partner Gene MYO18A in a Child With Acute Myeloid Leukemia,” Cancer Genetics 205 (2012): 261–265, https://doi.org/10.1016/j.cancergen.2012.02.006.

[27] A. Xiong, J. Haithcock, Y. Liu, et al., “The Shaker-1 Mouse Myosin VIIa Deafness Mutation Results in a Severely Reduced Rate of the ATP Hydrolysis Step,” Journal of Biological Chemistry 293 (2018): 819–829, https://doi.org/10.1074/jbc.M117.810119.

[28] I.-M. Yu, V. J. Planelles-Herrero, Y. Sourigues, et al., “Myosin 7 and Its Adaptors Link Cadherins to Actin,” Nature Communications 8 (2017): 15864, https://doi.org/10.1038/ncomms15864.

[29] O. Pylypenko, L. Song, A. Shima, Z. Yang, A. M. Houdusse, and H. L. Sweeney, “Myosin VI Deafness Mutation Prevents the Initiation of Processive Runs on Actin,” Proceedings of the National Academy of Sciences of the United States of America 112 (2015): E1201–E1209, https://doi.org/10.1073/pnas.1420989112.

[30] Z. Wang, M. Grange, T. Wagner, A. L. Kho, M. Gautel, and S. Raunser, “The Molecular Basis for Sarcomere Organization in Vertebrate Skeletal Muscle,” Cell 184 (2021): 2135–2150.e13, https://doi.org/10.1016/j.cell.2021.02.047.

[31] J. R. Homburger, E. M. Green, C. Caleshu, et al., “Multidimensional Structure–Function Relationships in Human β-Cardiac Myosin From Population-Scale Genetic Variation,” Proceedings of the National Academy of Sciences of the United States of America 113 (2016): 6701–6706, https://doi.org/10.1073/pnas.1606950113.

[32] M. Gyimesi, Á. I. Horváth, D. Túrós, et al., “Single Residue Variation in Skeletal Muscle Myosin Enables Direct and Selective Drug Targeting for Spasticity and Muscle Stiffness,” Cell 183 (2020): 335–346.e13, https://doi.org/10.1016/j.cell.2020.08.050.

[33] S. Nag, R. F. Sommese, Z. Ujfalusi, et al., “Contractility Parameters of Human β-Cardiac Myosin With the Hypertrophic Cardiomyopathy Mutation R403Q Show Loss of Motor Function,” Science Advances 1 (2015): e1500511, https://doi.org/10.1126/sciadv.1500511.

[34] C. A. Sewry, J. M. Laitila, and C. Wallgren-Pettersson, “Nemaline Myopathies: A Current View,” Journal of Muscle Research and Cell Motility 40 (2019): 111–126, https://doi.org/10.1007/s10974-019-09519-9.

[35] H. S. Alsaif, A. Alshehri, R. A. Sulaiman, et al., “MYH1 is a Candidate Gene for Recurrent Rhabdomyolysis in Humans,” American Journal of Medical Genetics Part A 185 (2021): 2131–2135, https://doi.org/10.1002/ajmg.a.62188.

[36] M. J. Tyska, E. Hayes, M. Giewat, C. E. Seidman, J. G. Seidman, and D. M. Warshaw, “Single-Molecule Mechanics of R403Q Cardiac Myosin Isolated From the Mouse Model of Familial Hypertrophic Cardiomyopathy,” Circulation Research 86 (2000): 737–744, https://doi.org/10.1161/01.res.86.7.737.

[37] S. Nag, D. V. Trivedi, S. S. Sarkar, et al., “The Myosin Mesa and the Basis of Hypercontractility Caused by Hypertrophic Cardiomyopathy Mutations,” Nature Structural & Molecular Biology 24 (2017): 525–533, https://doi.org/10.1038/nsmb.3408.

[38] S. S. Sarkar, D. V. Trivedi, M. M. Morck, et al., “The Hypertrophic Cardiomyopathy Mutations R403Q and R663H Increase the Number of Myosin Heads Available to Interact With Actin,” Science Advances 6 (2020): eaax0069, https://doi.org/10.1126/sciadv.aax0069.

[39] M. M. Morck, D. Bhowmik, D. Pathak, A. Dawood, J. Spudich, and K. M. Ruppel, “Hypertrophic Cardiomyopathy Mutations in the Pliant and Light Chain-Binding Regions of the Lever Arm of Human β-Cardiac Myosin Have Divergent Effects on Myosin Function,” eLife 11 (2022): e76805, https://doi.org/10.7554/eLife.76805.

[40] A. S. Vander Roest, C. Liu, M. M. Morck, et al., “Hypertrophic Cardiomyopathy β-Cardiac Myosin Mutation (P710R) Leads to Hypercontractility by Disrupting Super Relaxed state,” Proceedings of the National Academy of Sciences of the United States of America 118 (2021): e2025030118, https://doi.org/10.1073/pnas.2025030118.

[41] C. Risi, L. U. Schäfer, B. Belknap, et al., “High-Resolution Cryo-EM Structure of the Cardiac Actomyosin Complex,” Structure 29 (2021): 50–60.e4, https://doi.org/10.1016/j.str.2020.09.013.

[42] L. Alamo, J. S. Ware, A. Pinto, et al., “Effects of Myosin Variants on Interacting-Heads Motif Explain Distinct Hypertrophic and Dilated Cardiomyopathy Phenotypes,” eLife 6 (2017): e24634, https://doi.org/10.7554/eLife.24634.

[43] J. von der Ecken, S. M. Heissler, S. Pathan-Chhatbar, D. J. Manstein, and S. Raunser, “Cryo-EM Structure of a Human Cytoplasmic Actomyosin Complex at Near-Atomic Resolution,” Nature 534 (2016): 724–728, https://doi.org/10.1038/nature18295.

[44] T. Fujii and K. Namba, “Structure of Actomyosin Rigour Complex at 5.2 Å Resolution and Insights Into the ATPase Cycle Mechanism,” Nature Communications 8 (2017): 13969, https://doi.org/10.1038/ncomms13969.

[45] C. Banerjee, Z. Hu, Z. Huang, et al., “The Structure of the Actin-Smooth Muscle Myosin Motor Domain Complex in the Rigor State,” Journal of Structural Biology 200 (2017): 325–333, https://doi.org/10.1016/j.jsb.2017.10.003.

[46] M. H. Doran, E. Pavadai, M. J. Rynkiewicz, et al., “Cryo-EM and Molecular Docking Shows Myosin Loop 4 Contacts Actin and Tropomyosin on Thin Filaments,” Biophysical Journal 119 (2020): 821–830, https://doi.org/10.1016/j.bpj.2020.07.006.

[47] S. F. Wulf, V. Ropars, S. Fujita-Becker, et al., “Force-Producing ADP State of Myosin Bound to Actin,” Proceedings of the National Academy of Sciences of the United States of America 113 (2016): E1844–E1852, https://doi.org/10.1073/pnas.1516598113.

[48] D. Tamborrini, Z. Wang, T. Wagner, et al., “Structure of the Native Myosin Filament in the Relaxed Cardiac Sarcomere,” Nature 623 (2023): 863–871, https://doi.org/10.1038/s41586-023-06690-5.

[49] F. Merino, S. Pospich, J. Funk, et al., “Structural Transitions of F-Actin Upon ATP Hydrolysis at Near-Atomic Resolution Revealed by Cryo-EM,” Nature Structural & Molecular Biology 25 (2018): 528–537, https://doi.org/10.1038/s41594-018-0074-0.

[50] P. S. Gurel, L. Y. Kim, P. V. Ruijgrok, T. Omabegho, Z. Bryant, and G. M. Alushin, “Cryo-EM Structures Reveal Specialization at the Myosin VI-Actin Interface and a Mechanism of Force Sensitivity,” eLife 6 (2017): e31125, https://doi.org/10.7554/eLife.31125.

[51] W. Ma, T. S. Mcmillen, M. C. Childers, H. Gong, M. Regnier, and T. Irving, “Structural OFF/ON Transitions of Myosin in Relaxed Porcine Myocardium Predict Calcium-Activated Force,” Proceedings of the National Academy of Sciences of the United States of America 120 (2023): e2207615120, https://doi.org/10.1073/pnas.2207615120.

[52] J. Von Der Ecken, M. Müller, W. Lehman, D. J. Manstein, P. A. Penczek, and S. Raunser, “Structure of the F-Actin–Tropomyosin Complex,” Nature 519 (2014): 114–117, https://doi.org/10.1038/nature14033.

[53] W. Kabsch, H. G. Mannherz, D. Suck, E. F. Pai, and K. C. Holmes, “Atomic Structure of the Actin:DNase I Complex,” Nature 347 (1990): 37–44, https://doi.org/10.1038/347037a0.

[54] R. Dominguez and K. C. Holmes, “Actin Structure and Function,” Annual Review of Biophysics 40 (2011): 169–186, https://doi.org/10.1146/annurev-biophys-042910-155359.

[55] F. Houle, A. Poirier, J. Dumaresq, and J. Huot, “DAP Kinase Mediates the Phosphorylation of Tropomyosin-1 Downstream of the ERK Pathway, Which Regulates the Formation of Stress Fibers in Response to Oxidative Stress,” Journal of Cell Science 120 (2007): 3666–3677, https://doi.org/10.1242/jcs.003251.

[56] J. J. Sheng and J. P. Jin, “Gene Regulation, Alternative Splicing, and Posttranslational Modification of Troponin Subunits in Cardiac Development and Adaptation: A Focused Review,” Frontiers in Physiology 5 (2014): 165, https://doi.org/10.3389/fphys.2014.00165.

[57] L. Burbaum, J. Schneider, S. Scholze, et al., “Molecular-Scale Visualization of Sarcomere Contraction Within Native Cardiomyocytes,” Nature Communications 12 (2021): 4086, https://doi.org/10.1038/s41467-021-24049-0.

[58] R. M. Paranal, P. Teekakirikul, C. Y. Ho, D. Fatkin, and C. E. Seidman, “Genetic Cardiomyopathies,” in Emery and Rimoin's Principles and Practice of Medical Genetics and Genomics, 7th ed., ed. R. E. Pyeritz, B. R. Korf, and W. W. Grody (Academic Press, 2020), 77–114.

[59] O. M. Hernandez, M. Jones, G. Guzman, and D. Szczesna-Cordary, “Myosin Essential Light Chain in Health and Disease,” American Journal of Physiology-Heart and Circulatory Physiology 292 (2007): H1643–H1654, https://doi.org/10.1152/ajpheart.00931.2006.

[60] R. Dominguez, Y. Freyzon, K. M. Trybus, and C. Cohen, “Crystal Structure of a Vertebrate Smooth Muscle Myosin Motor Domain and Its Complex With the Essential Light Chain,” Cell 94 (1998): 559–571, https://doi.org/10.1016/s0092-8674(00)81598-6.

[61] T. Konno, S. Chang, J. G. Seidman, and C. E. Seidman, “Genetics of Hypertrophic Cardiomyopathy,” Current Opinion in Cardiology 25 (2010): 205–209, https://doi.org/10.1097/HCO.0b013e3283375698.

[62] P. A. Harvey and L. A. Leinwand, “Cellular Mechanisms of Cardiomyopathy,” Journal of Cell Biology 194 (2011): 355–365, https://doi.org/10.1083/jcb.201101100.

[63] C. Semsarian, J. Ingles, M. S. Maron, and B. J. Maron, “New Perspectives on the Prevalence of Hypertrophic Cardiomyopathy,” Journal of the American College of Cardiology 65 (2015): 1249–1254, https://doi.org/10.1016/j.jacc.2015.01.019.

[64] A. S. Adhikari, D. V. Trivedi, S. S. Sarkar, et al., “β-Cardiac Myosin Hypertrophic Cardiomyopathy Mutations Release Sequestered Heads and Increase Enzymatic Activity,” Nature Communications 10 (2019): 2685, https://doi.org/10.1038/s41467-019-10555-9.

[65] D. Ntelios, S. Meditskou, G. Efthimiadis, et al., “α-Myosin Heavy Chain (MYH6) in Hypertrophic Cardiomyopathy: Prominent Expression in Areas With Vacuolar Degeneration of Myocardial Cells,” Pathology International 72 (2022): 308–310, https://doi.org/10.1111/pin.13216.

[66] A. A. T. Geisterfer-Lowrance, M. Christe, D. A. Conner, et al., “A Mouse Model of Familial Hypertrophic Cardiomyopathy,” Science 272 (1996): 731–734, https://doi.org/10.1126/science.272.5262.731.

[67] K. Seo, Y. Yamamoto, A. Kirillova, et al., “Improved Cardiac Performance and Decreased Arrhythmia in Hypertrophic Cardiomyopathy With Non–β-Blocking R-Enantiomer Carvedilol,” Circulation 148 (2023): 1691–1704, https://doi.org/10.1161/circulationaha.123.065017.

[68] Y. Huang, H. Lu, X. Ren, et al., “Fropofol Prevents Disease Progression in Mice With Hypertrophic Cardiomyopathy,” Cardiovascular Research 116 (2020): 1175–1185, https://doi.org/10.1093/cvr/cvz218.

[69] A. Amoresano and P. Pucci, “Mass Spectrometry in Metabolomics,” in Metabolomics Perspectives, ed. J. Troisi (Academic Press, 2022), 109–147.

[70] Y. Shi, A. G. Murzin, B. Falcon, et al., “Cryo-EM Structures of Tau filaments From Alzheimer's Disease With PET Ligand APN-1607,” Acta Neuropathologica 141 (2021): 697–708, https://doi.org/10.1007/s00401-021-02294-3.

[71] P. M. Seidler, K. A. Murray, D. R. Boyer, et al., “Structure-Based Discovery of Small Molecules That Disaggregate Alzheimer's Disease Tissue Derived Tau Fibrils In Vitro,” Nature Communications 13 (2022): 5451, https://doi.org/10.1038/s41467-022-32951-4.

[72] Q. Zhao, Y. Fan, W. Zhao, et al., “A Tau PET Tracer PBB3 Binds to TMEM106B Amyloid Fibril in Brain,” Cell Discovery 10 (2024): 50, https://doi.org/10.1038/s41421-024-00674-z.

[73] S. Pospich, H. L. Sweeney, A. Houdusse, and S. Raunser, “High-Resolution Structures of the Actomyosin-V Complex in Three Nucleotide States Provide Insights Into the Force Generation Mechanism,” eLife 10 (2021): e73724, https://doi.org/10.7554/eLife.73724.

[74] M. C. Viswanathan, R. C. Tham, W. A. Kronert, et al., “Myosin Storage Myopathy Mutations Yield Defective Myosin Filament Assembly In Vitro and Disrupted Myofibrillar Structure and Function In Vivo,” Human Molecular Genetics 26 (2017): 4799–4813, https://doi.org/10.1093/hmg/ddx359.

[75] D. V. Trivedi, S. Nag, A. Spudich, K. M. Ruppel, and J. A. Spudich, “The Myosin Family of Mechanoenzymes: From Mechanisms to Therapeutic Approaches,” Annual Review of Biochemistry 89 (2020): 667–693, https://doi.org/10.1146/annurev-biochem-011520-105234.

[76] J. S. Amberger, C. A. Bocchini, F. Schiettecatte, A. F. Scott, and A. O. Hamosh, “OMIM.org: Online Mendelian Inheritance in Man (OMIM®), an Online Catalog of Human Genes and Genetic Disorders,” Nucleic Acids Research 43 (2015): D789–D798, https://doi.org/10.1093/nar/gku1205.

[77] J. R. Homburger, E. M. Green, C. Caleshu, et al., “Multidimensional Structure–Function Relationships in Human β-Cardiac Myosin From Population-Scale Genetic Variation,” Proceedings of the National Academy of Sciences of the United States of America 113 (2016): 6701–6706, https://doi.org/10.1073/pnas.1606950113.

[78] M. P. M. Schubert, D. Zucker-Franklin, A. Rimon, and E. C. Franklin, “The Characterization of Soluble Amyloid Prepared in Water,” Journal of Clinical Investigation 47 (1968): 924–933, https://doi.org/10.1172/jci105784.

[79] K. Annamalai, K.-H. Gührs, R. Koehler, et al., “Polymorphism of Amyloid Fibrils In Vivo,” Angewandte Chemie International Edition 55 (2016): 4822–4825, https://doi.org/10.1002/anie.201511524.

[80] U. K. Laemmli, “Cleavage of Structural Proteins During the Assembly of the Head of Bacteriophage T4,” Nature 227 (1970): 680–685, https://doi.org/10.1038/227680a0.

[81] C. A. Rohl, C. E. Strauss, K. M. Misura, and D. Baker, “Protein Structure Prediction Using Rosetta,” Methods in Enzymology 383 (2004): 66–93, https://doi.org/10.1016/S0076-6879(04)83004-0.

[82] M. D. Tyka, D. A. Keedy, I. André, et al., “Alternate States of Proteins Revealed by Detailed Energy Landscape Mapping,” Journal of Molecular Biology 405 (2011): 607–618, https://doi.org/10.1016/j.jmb.2010.11.008.

[83] P. B. Stranges and B. Kuhlman, “A Comparison of Successful and Failed Protein Interface Designs Highlights the Challenges of Designing Buried Hydrogen Bonds,” Protein Science 22 (2013): 74–82, https://doi.org/10.1002/pro.2187.

[84] S. Q. Zheng, E. Palovcak, J.-P. Armache, K. A. Verba, Y. Cheng, and D. A. Agard, “MotionCor2: Anisotropic Correction of Beam-induced Motion for Improved Cryo-Electron Microscopy,” Nature Methods 14 (2017): 331–332, https://doi.org/10.1038/nmeth.4193.

[85] A. Rohou and N. Grigorieff, “CTFFIND4: Fast and Accurate Defocus Estimation From Electron Micrographs,” Journal of Structural Biology 192 (2015): 216–221, https://doi.org/10.1016/j.jsb.2015.08.008.

[86] S. H. W. Scheres, “Amyloid Structure Determination in RELION-3.1,” Acta Crystallographica Section D Structural Biology 76 (2020): 94–101, https://doi.org/10.1107/s2059798319016577.

[87] S. Bienert, A. Waterhouse, T. A. P. De Beer, et al., “The SWISS-MODEL Repository—New Features and Functionality,” Nucleic Acids Research 45 (2017): D313–D319, https://doi.org/10.1093/nar/gkw1132.

[88] P. D. Adams, P. V. Afonine, G. Bunkóczi, et al., “PHENIX: A Comprehensive Python-Based System for Macromolecular Structure Solution,” Acta Crystallographica Section D Biological Crystallography 66 (2010): 213–221, https://doi.org/10.1107/s0907444909052925.

[89] P. Emsley, B. Lohkamp, W. G. Scott, and K. Cowtan, “Features and Development of Coot,” Acta Crystallographica Section D Biological Crystallography 66 (2010): 486–501, https://doi.org/10.1107/s0907444910007493.

RIGHTS & PERMISSIONS

2026 The Author(s). Aggregate published by SCUT, AIEI, and John Wiley & Sons Australia, Ltd.